Aphria Inc.’s U.S.-listed shares slid 9% Tuesday, after the Canadian cannabis company posted weaker-than-expected revenue for its fiscal second quarter and revised down its guidance to reflect issues including a slower rollout of retail locations in Ontario. Read More...
Aphria Inc.’s U.S.-listed shares slid 9% Tuesday, after the Canadian cannabis company posted weaker-than-expected revenue for its fiscal second quarter and revised down its guidance to reflect issues including a slower rollout of retail locations in Ontario.
Add Comment